Rocephin

Company: Roche
Approval Status: Approved January 1998
Treatment for: Pediatric otitis media
Areas: ENT (Ear, Nose and Throat); Pediatrics
Possible similar drugs: Rocephin

| General Information | Clinical Results |

General Information

Hoffmann-LaRoche's antibiotic Rocephin (ceftriaxone sodium) has been approved as a one dose injection for the treatment of bacterial otitis media in children. The drug was previously approved for use as a 10-day multiple dose oral treatment.

Clinical Results

In clinical trials involving 2.450 children demonstrated that the drug, when administered intramuscularly as a single dose, is comparable to standard 10-day multiple dose oral treatments. The injectable form was found to be 100% effective in eradicating Hemophilus influenzae, Moraxella catarrhalis and susceptible Streptococcus pneumoniae.

< back to top

Rocephin Drug Information

The Rocephin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.